Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
STAT+
Biotech
Health
The Readout

Who had a very bad Good Friday & a test for Incyte

  • Damian Garde
  • Meghana Keshavan

By Damian Garde and Meghana Keshavan April 17, 2017

Reprints
The READOUT
Alex Hogan/STAT

The Readout for April 17, 2017

About the Authors Reprints

Damian Garde

Damian Garde

National Biotech Reporter

Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

Carrying the torch of his slain brother, a Chicago…
Carrying the torch of his slain brother, a Chicago ER doctor struggles against the violence around…
Tanzania reports a Marburg outbreak, Africa’s second this year
Tanzania reports a Marburg outbreak, Africa’s second this year
Douglas Melton, noted stem cell researcher, leaves Harvard for…
Douglas Melton, noted stem cell researcher, leaves Harvard for Vertex to create diabetes treatments
Regeneron targets obesity, a new microbiome deal, & comparing…
Regeneron targets obesity, a new microbiome deal, & comparing cancer drug costs
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries…
Should the feds investigate Aduhelm? Plus: biotech’s biggest binaries & regenerating heart tissue
Docs disagree with FDA on Aduhelm, Swiss giants pinch…
Docs disagree with FDA on Aduhelm, Swiss giants pinch pennies, & one SPAC makes it rain

Recommended Stories